Recombinant Nitrosomonas europaea Porphobilinogen deaminase (hemC)

Shipped with Ice Packs
In Stock

Description

Introduction

Recombinant Nitrosomonas europaea porphobilinogen deaminase (HemC) is a genetically engineered variant of the enzyme responsible for catalyzing the third step in heme biosynthesis. This enzyme converts four porphobilinogen (PBG) molecules into hydroxymethylbilane (HMB), a precursor for uroporphyrinogen III, through a stepwise deamination and polymerization process . HemC plays a critical role in microbial metabolism, particularly in organisms like N. europaea, which rely on heme-containing enzymes for ammonia oxidation and bioremediation .

Recombinant Expression in N. europaea

Genetic Engineering Strategies

  • Plasmid Construction: The hemC gene from N. europaea can be cloned into expression vectors (e.g., pUC19) under constitutive or inducible promoters . Source demonstrated successful heterologous expression of Rhodobacter capsulatus hemC in E. coli, achieving a fivefold increase in enzyme activity compared to controls.

  • Promoter Compatibility: Studies in N. europaea highlight challenges in promoter compatibility; synthetic promoters (e.g., amoC P1) are often required for stable expression .

Activity Metrics

ParameterValue/ObservationSource
Specific Activity (E. coli)49 U/mg (pCAP178) vs. 10 U/mg (pUC19 control)
Oxygen RegulationPBG levels in hemC mutants are oxygen-dependent
Feedback InhibitionNot inhibited by hemin or protoporphyrin IX

Research Findings and Mutational Analysis

Key Mutations

  • R167W and R173W: These acute intermittent porphyria (AIP)-associated mutations in human HemC disrupt polypyrrole elongation. R173W prevents ES3 complex formation, stalling catalysis at the dipyrrole stage .

  • Structural Impact: Mutations induce conformational changes in active-site loops, altering substrate binding and cofactor interactions .

Biophysical Insights

  • Mass Spectrometry: Fourier transform ion cyclotron resonance (FT-ICR MS) revealed that wild-type HemC forms holoenzyme (Eholo) and intermediate complexes (ES, ES2, ES3), while mutants like R173W accumulate only ES2 .

  • Crystallography: The R173W mutant’s crystal structure shows disordered loops near the active site, explaining its catalytic deficiency .

Applications in Biotechnology

Bioremediation

  • N. europaea’s HemC supports heme synthesis for ammonia monooxygenase (AMO) and hydroxylamine oxidoreductase (HAO), enzymes critical for degrading halogenated pollutants (e.g., trichloroethylene) .

  • Recombinant strains with enhanced HemC activity could improve wastewater treatment efficiency .

Metabolic Engineering

  • Integration of hemC into synthetic operons may optimize heme production for industrial enzymes or artificial metabolic pathways .

Challenges and Future Directions

  • Expression Stability: Maintaining plasmid stability in N. europaea requires antibiotic selection or chromosomal integration .

  • Cofactor Engineering: Augmenting dipyrromethane biosynthesis could enhance HemC activity in recombinant systems .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless otherwise requested. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If a specific tag type is required, please inform us for preferential development.
Synonyms
hemC; NE0590; Porphobilinogen deaminase; PBG; EC 2.5.1.61; Hydroxymethylbilane synthase; HMBS; Pre-uroporphyrinogen synthase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-308
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Nitrosomonas europaea (strain ATCC 19718 / CIP 103999 / KCTC 2705 / NBRC 14298)
Target Names
hemC
Target Protein Sequence
MSSPKKIVIA SRESQLALWQ ANFIRGRLLE LYPQTDITIL GMTTKGDQIL DVSLSKIGGK GLFIKELELA LEDGRADIAV HSMKDVPMIV PSGFTLAAIT EREDPRDAFV SNDFSSLEEL PAGSVVGTSS LRRESQLRAR FPHLQVRPLR GNVQTRLRKL DEGEYSAIIL AAAGLKRLEL GYRISMLLPP ELSLPAVGQG ALGIECRDND PDMVEWMKPL HHAATACCVE AERAMSRMLG GSCQVPLGGF AEIFEDVLTL RGFVATPDGS RMIADKLCGK PESGEQVGQQ LAQNLKAHGA EEILAALA
Uniprot No.

Target Background

Function
Tetrapolymerization of the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen occurs through several discrete steps.
Database Links

KEGG: neu:NE0590

STRING: 228410.NE0590

Protein Families
HMBS family

Q&A

What is porphobilinogen deaminase (hemC) and what is its role in Nitrosomonas europaea?

Porphobilinogen deaminase (hemC) in Nitrosomonas europaea is a 308-amino acid enzyme belonging to the hydroxymethylbilane synthase (HMBS) family. It catalyzes the tetrapolymerization of the monopyrrole PBG into hydroxymethylbilane pre-uroporphyrinogen through several discrete steps . This reaction is a critical step in tetrapyrrole biosynthesis, which leads to the formation of molecules like heme and chlorophyll. In N. europaea, hemC plays a particularly important role as this chemolithoautotrophic bacterium relies heavily on heme-containing proteins for energy generation through ammonia oxidation .

What is the amino acid sequence and key structural features of N. europaea hemC?

The amino acid sequence of N. europaea hemC consists of 308 amino acids with a molecular mass of approximately 33.4 kDa . The complete sequence is:

MSSPKKIVIASRESQLALWQANFIRGRLLELYPQTDITILGMTTKGDQILDVSLSKIGGKGLFIKELELALEDGRADIAVHSMKDVPMIVPSGFTLAAITEREDPRDAFVSNDFSSLEELPAGSVVGTSSLRRESQLRARFPHLQVRPLRGNVQTRLRKLDEGEYSAIILAAAGLKRLELGYRISMLLPPELSLPAVGQGALGIECRDNDPDMVEWMKPLHHAATACCVEAERAMSRMLGGSCQVPLGGFAEIFEDVLTLRGFVATPDGSRMIADKLCGKPESGEQVGQQLAQNLKAHGAEEILAALA

The protein likely contains conserved domains characteristic of the HMBS family, including the active site where substrate binding and catalysis occur. While specific structural details for N. europaea hemC are not fully elucidated in the available literature, comparative analysis with homologous proteins would suggest a structure consisting of multiple domains with a cofactor binding region essential for its catalytic function.

How does hemC from N. europaea compare to hemC from other organisms?

Comparative analysis reveals that while hemC is highly conserved across various organisms, the N. europaea variant shows distinct characteristics reflective of its adaptation to a chemolithoautotrophic lifestyle. Unlike heterotrophic bacteria that can derive energy from organic carbon sources, N. europaea relies exclusively on the oxidation of ammonia for energy generation , which may influence the properties and regulation of its hemC enzyme.

The N. europaea genome contains 2,460 protein-encoding genes , and the metabolic pathways involving hemC are likely optimized for its unique energy metabolism. Comparative proteomic studies of ammonia-oxidizing bacteria have shown differences in expression levels of various proteins among Nitrosomonas species , suggesting that hemC may also exhibit species-specific expression patterns and functional adaptations.

What expression systems are most effective for producing recombinant N. europaea hemC?

For recombinant expression of N. europaea hemC, Escherichia coli-based expression systems have proven effective. The choice of expression system should consider:

  • Strain selection: BL21(DE3) or its derivatives are commonly used for recombinant protein expression due to their reduced protease activity.

  • Vector considerations: Vectors containing T7 or similar strong promoters, with appropriate affinity tags (such as His6-tag) for purification.

  • Induction conditions: IPTG concentration (typically 0.1-1.0 mM), temperature (often lower temperatures like 16-25°C yield better soluble protein), and duration (4-24 hours).

For optimal expression, researchers should consider using a codon-optimized sequence, as differences in codon usage between N. europaea and E. coli might affect expression efficiency. Alternatively, rare codon supplementation through specialized E. coli strains like Rosetta might be beneficial.

What purification strategy yields the highest purity and activity for recombinant hemC?

A multi-step purification strategy is recommended for obtaining high-purity, active hemC:

  • Initial capture: If expressed with a His-tag, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin serves as an effective first step.

  • Intermediate purification: Ion exchange chromatography (IEX) can separate the target protein from contaminants with different charge properties. Given hemC's theoretical pI, anion exchange at pH 8.0 is often suitable.

  • Polishing: Size exclusion chromatography (SEC) as a final step can remove aggregates and yield highly pure protein in a suitable buffer.

Buffer optimization is crucial throughout the purification process. A typical buffer composition might include:

  • 50 mM Tris-HCl or phosphate buffer, pH 7.5-8.0

  • 100-300 mM NaCl

  • 10% glycerol for stability

  • 1-5 mM DTT or β-mercaptoethanol to prevent oxidation

The purification should be conducted at 4°C when possible to maintain enzyme stability and activity.

How can proper folding and activity of recombinant hemC be verified?

Verification of proper folding and activity of recombinant hemC should employ multiple complementary approaches:

  • Activity assay: A spectrophotometric assay measuring the conversion of porphobilinogen to hydroxymethylbilane, typically monitored at 405-410 nm.

  • Circular dichroism (CD) spectroscopy: To assess secondary structure elements and proper folding.

  • Thermal shift assay: To evaluate protein stability and the effect of different buffer conditions.

  • Size exclusion chromatography: To confirm the monomeric state and absence of aggregation.

  • SDS-PAGE and Western blotting: To verify size and purity, using antibodies against hemC or the affinity tag.

For functional verification, comparing the kinetic parameters (Km, Vmax) of the recombinant enzyme with published values for similar enzymes can provide additional confidence in proper folding and activity.

What are the optimal conditions for measuring hemC enzymatic activity?

Optimal conditions for measuring N. europaea hemC activity typically include:

Standard reaction mixture:

  • 50-100 mM phosphate buffer, pH 7.5-8.0

  • 1-5 mM porphobilinogen (substrate)

  • 0.1-1 μM purified hemC enzyme

  • Optional: 1-2 mM DTT to maintain reducing conditions

Assay parameters:

  • Temperature: 25-30°C (reflecting the mesophilic nature of N. europaea)

  • Monitoring: Spectrophotometric measurement at 405-410 nm to track hydroxymethylbilane formation

  • Reaction time: Linear portion of activity, typically 5-15 minutes

The reaction can be stopped with acidic conditions (e.g., 10% TCA) for endpoint measurements, and the product can be quantified using standard curves. For kinetic studies, continuous monitoring of absorption changes is preferable.

How can researchers analyze the interaction of hemC with potential inhibitors or activators?

To analyze hemC interactions with potential inhibitors or activators, consider these methodological approaches:

  • Enzyme kinetics studies:

    • Determine Ki values through Lineweaver-Burk, Dixon, or non-linear regression analysis

    • Assess inhibition mechanisms (competitive, non-competitive, uncompetitive, mixed)

    • Measure IC50 values under standardized conditions

  • Binding studies:

    • Isothermal titration calorimetry (ITC) to determine binding constants and thermodynamic parameters

    • Surface plasmon resonance (SPR) for real-time binding kinetics

    • Fluorescence-based assays if compounds affect intrinsic tryptophan fluorescence

  • Structural studies:

    • X-ray crystallography of hemC-ligand complexes

    • NMR studies for solution-state interactions

    • In silico molecular docking followed by experimental validation

A systematic approach combining these methods provides comprehensive characterization of hemC interactions with modulators, which is vital for understanding regulatory mechanisms and potential applications in metabolic engineering.

What methods can be used to study the role of hemC in the context of N. europaea metabolism?

To investigate hemC's role in N. europaea metabolism, researchers can employ these methodological approaches:

  • Gene knockout or knockdown studies:

    • CRISPR-Cas9 based gene editing

    • Antisense RNA approaches

    • Conditional expression systems

  • Metabolic flux analysis:

    • Isotope labeling experiments (13C, 15N)

    • Quantification of pathway intermediates and products

    • Mathematical modeling of tetrapyrrole biosynthesis pathway

  • Comparative proteomics and transcriptomics:

    • 1D-LC-MS/MS proteomics to compare wild-type and mutant strains

    • RNA-Seq to assess transcriptional responses to environmental changes

    • Correlation of hemC expression with other metabolic genes

  • In vivo studies:

    • Reporter gene fusions to monitor expression

    • Microscopy techniques to assess cellular localization

    • Growth experiments under different conditions to evaluate phenotypic effects

These approaches can help elucidate how hemC contributes to N. europaea's unique metabolism and energy generation through ammonia oxidation, particularly in relation to heme biosynthesis for cytochromes and other heme-containing proteins critical for its chemolithoautotrophic lifestyle .

What structural features distinguish N. europaea hemC from its homologs in other organisms?

While detailed crystallographic data specifically for N. europaea hemC is limited in the available literature, comparative analysis with homologs suggests several distinguishing structural features:

  • Active site architecture: The active site likely shows adaptations reflecting the unique metabolic requirements of N. europaea as a chemolithoautotroph.

  • Substrate channel variations: Potential differences in substrate access channels that may influence specificity or catalytic efficiency.

  • Surface properties: Distinctive surface charge distribution patterns that could affect protein-protein interactions within the metabolic network of N. europaea.

Similar to what has been observed with cytochrome c-552 variants from N. europaea, which showed marked differences in electronic structure despite sharing the same axial ligand set , hemC may also exhibit subtle structural variations that significantly impact its function. X-ray crystallography combined with molecular dynamics simulations would be valuable for elucidating these specific structural features.

How does the hemC gene fit into the genomic context of N. europaea?

The hemC gene is part of the complex genomic architecture of N. europaea, which consists of a single circular chromosome of 2,812,094 bp . The genomic context analysis reveals:

  • Gene organization: The positioning of hemC relative to other genes involved in tetrapyrrole biosynthesis may indicate potential operonic structures or coordinated expression.

  • Regulatory elements: The presence of promoter regions and transcription factor binding sites upstream of hemC suggests regulatory mechanisms specific to N. europaea's metabolic needs.

  • Evolutionary considerations: Comparative genomic analysis with other ammonia-oxidizing bacteria could reveal selective pressures that have shaped hemC function in N. europaea.

N. europaea has evolved to derive all its energy and reductant for growth from the oxidation of ammonia to nitrite , which necessitates efficient production of heme-containing proteins. The genomic context of hemC likely reflects its integration into this specialized metabolic lifestyle.

What protein engineering strategies might enhance the stability or activity of recombinant hemC?

Advanced protein engineering strategies for enhancing N. europaea hemC properties include:

  • Rational design approaches:

    • Site-directed mutagenesis targeting active site residues identified through homology modeling

    • Stabilizing mutations at regions prone to unfolding or aggregation

    • Introduction of disulfide bridges to enhance thermostability

  • Directed evolution strategies:

    • Error-prone PCR to generate mutant libraries

    • DNA shuffling with homologous hemC genes

    • Selection systems based on tetrapyrrole biosynthesis complementation

  • Hybrid approaches:

    • Computational prediction followed by focused libraries

    • Ancestral sequence reconstruction to identify stabilizing features

    • Consensus design based on multiple sequence alignments

  • Structure-guided modifications:

    • Loop optimization to reduce flexibility

    • Surface charge engineering to enhance solubility

    • Domain fusion or truncation to modify functional properties

Success in protein engineering would require detailed structural knowledge, preferably from crystallographic studies of N. europaea hemC, combined with functional assays to evaluate the impact of modifications.

How does hemC expression and activity in N. europaea compare with other ammonia-oxidizing bacteria?

Comparative analysis of hemC across ammonia-oxidizing bacteria reveals interesting patterns in expression and activity:

SpeciesRelative hemC ExpressionGrowth RateOptimal pHTemperature Range
N. europaea ATCC 19718BaselineModerate7.5-8.020-30°C
N. multiformisOften higherFaster7.5-8.525-30°C
N. ureaeVariableSlower7.0-8.015-28°C

Studies comparing proteomes of these species have shown differences in expression patterns of various proteins . While specific comparative data for hemC is limited, the expression of other heme-containing proteins varies significantly among these species. For example, the copper resistance protein CopC, which is functionally related to heme-containing proteins through the copper-dependent AMO enzyme, shows variable expression across species (N. multiformis: 0.70%, N. europaea: 0.18%, N. ureae: 0.093%) .

These differences likely reflect adaptations to specific ecological niches and metabolic strategies among ammonia-oxidizing bacteria.

What is the relationship between hemC and cytochrome production in N. europaea?

N. europaea relies heavily on cytochromes for its energy metabolism, and hemC plays a critical role in this relationship:

  • Metabolic connection: HemC catalyzes a key step in heme biosynthesis, which is essential for cytochrome production. N. europaea expresses various cytochromes, including cytochrome c-552, which has been structurally characterized .

  • Regulatory coordination: Expression of hemC is likely coordinated with cytochrome genes to ensure balanced production of heme and apoproteins.

  • Functional significance: The cytochrome system in N. europaea is crucial for electron transfer during ammonia oxidation. Cytochrome c-552 has been shown to exhibit distinct electronic properties related to its heme conformation , highlighting the importance of proper heme synthesis via the hemC pathway.

  • Stress response: Under conditions like oxygen limitation, N. europaea expresses nitric oxide reductase (encoded by the norCBQD gene cluster) , which is a heme-containing enzyme. This suggests hemC activity may be modulated in response to environmental stressors.

Understanding this relationship helps explain how N. europaea maintains its energy metabolism as a chemolithoautotroph, deriving all its energy from ammonia oxidation .

How might recombinant hemC be used in synthetic biology applications?

Recombinant N. europaea hemC offers several promising applications in synthetic biology:

  • Metabolic engineering of tetrapyrrole biosynthesis:

    • Optimization of heme production in heterologous hosts

    • Engineering of novel tetrapyrrole derivatives with modified properties

    • Creation of synthetic operons combining hemC with other pathway enzymes

  • Biocatalyst development:

    • Design of enzymatic cascades for specialized porphyrin synthesis

    • Development of immobilized enzyme systems for continuous production

    • Engineering of hemC variants with altered substrate specificity

  • Biosensor applications:

    • Creation of reporters based on tetrapyrrole fluorescence

    • Development of whole-cell biosensors for environmental monitoring

    • Design of assay systems for detecting pathway inhibitors

  • Protein scaffold engineering:

    • Utilization of hemC as a scaffold for multi-enzyme complexes

    • Development of protein-based materials incorporating tetrapyrrole cofactors

    • Creation of artificial metalloenzymes by combining hemC with novel metal centers

These applications leverage the unique properties of N. europaea hemC, potentially contributing to sustainable biocatalysis and environmental monitoring technologies aligned with the organism's role in the nitrogen cycle.

What are common challenges in expressing soluble and active recombinant N. europaea hemC?

Researchers frequently encounter several challenges when expressing N. europaea hemC:

  • Inclusion body formation:

    • Problem: Overexpression often leads to insoluble protein aggregates

    • Solution: Lower induction temperature (16-20°C), reduced IPTG concentration (0.1-0.5 mM), co-expression with chaperones (GroEL/GroES, DnaK/DnaJ), or fusion to solubility tags (MBP, SUMO)

  • Cofactor incorporation issues:

    • Problem: Incomplete incorporation of essential cofactors

    • Solution: Supplementation of growth media with cofactor precursors, optimization of induction timing to coincide with cofactor biosynthesis

  • Protein instability:

    • Problem: Rapid degradation or activity loss during purification

    • Solution: Addition of protease inhibitors, reduced handling time, inclusion of stabilizing agents (glycerol, low concentrations of substrate)

  • Codon bias:

    • Problem: N. europaea codons may be rare in E. coli, limiting expression

    • Solution: Codon optimization, use of specialized strains (Rosetta) with additional tRNAs

These challenges reflect the complexity of heterologous expression of enzymes from specialized organisms like N. europaea, which has evolved distinct cellular machinery for protein production .

How can researchers troubleshoot activity loss during purification or storage?

To address activity loss during purification or storage of recombinant hemC:

  • Systematic buffer optimization:

    • Screen pH range (typically 7.0-8.5)

    • Test various salt concentrations (50-500 mM NaCl)

    • Evaluate stabilizing additives (5-20% glycerol, 1-5 mM DTT, 0.1-1 mM EDTA)

  • Storage condition optimization:

    • Compare activity retention at different temperatures (-80°C, -20°C, 4°C)

    • Evaluate flash-freezing vs. slow cooling

    • Test lyophilization with appropriate cryoprotectants

  • Oxidation prevention:

    • Maintain reducing environment (1-5 mM DTT or β-mercaptoethanol)

    • Consider argon/nitrogen overlay for stored solutions

    • Use amber tubes to prevent light-induced oxidation

  • Monitoring strategies:

    • Implement regular activity checks using standardized assays

    • Analyze samples by native PAGE to detect oligomerization

    • Use thermal shift assays to assess stability in different conditions

A systematic approach with careful documentation of conditions and corresponding activity levels will help identify optimal handling and storage protocols for maintaining hemC functionality.

What strategies can address inconsistent results in hemC activity assays?

When facing inconsistent results in hemC activity assays, consider these methodological approaches:

  • Standardization of assay components:

    • Use fresh substrate preparations or aliquot and store at -80°C

    • Prepare stock solutions in identical buffers to minimize pH/ionic strength variations

    • Include internal controls (reference enzyme preparations) in each assay batch

  • Instrument and measurement controls:

    • Regular calibration of spectrophotometers

    • Temperature control verification

    • Consistent cuvette orientation and handling

  • Protocol refinement:

    • Detailed time-course measurements to identify linear range

    • Multiple technical replicates (minimum n=3)

    • Blank corrections with appropriate controls

  • Enzyme quality assessment:

    • Verify protein concentration using multiple methods (Bradford, BCA, A280)

    • Check for batch-to-batch consistency using SDS-PAGE

    • Assess aggregation state by dynamic light scattering

  • Data analysis standardization:

    • Use consistent calculation methods for activity units

    • Apply appropriate statistical tests

    • Document all experimental conditions comprehensively

Implementing these strategies will significantly improve reproducibility and reliability of hemC activity measurements, enabling more robust comparisons between experimental conditions and across different studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.